Vol. 18 No. 1 (2024): January-December 2024

Published: 2024-01-16

Editorial

  • Tuberculosis research: Quo vadis

    Nerges Mistry
    27-29
    DOI: https://doi.org/10.33393/dti.2024.3076

Review

  • Molecular targets and therapeutic potential of baicalein: a review

    Kavita Munjal, Yash Goel, Vinod Kumar Gauttam, Hitesh Chopra, Madhav Singla, Smriti, Saurabh Gupta, Rohit Sharma
    30-46
    DOI: https://doi.org/10.33393/dti.2024.2707
  • The dark side of drug repurposing. From clinical trial challenges to antimicrobial resistance: analysis based on three major fields

    Iyad Y. Natsheh, Majd M. Alsaleh, Ahmad K. Alkhawaldeh, Duaa K. Albadawi, Maisa’ M. Darwish, Mohammed Jamal A. Shammout
    8-19
    DOI: https://doi.org/10.33393/dti.2024.3019

Original Research Article

Case report

  • Long-term response with the atypical reaction to nivolumab in microsatellite stability metastatic colorectal cancer: A case report

    Nataliya Babyshkina, Nataliya Popova, Evgeny Grigoryev , Tatyana Dronova , Polina Gervas , Alexey Dobrodeev , Dmitry Kostromitskiy , Victor Goldberg , Sergei Afanasiev , Nadejda Cherdyntseva
    4-7
    DOI: https://doi.org/10.33393/dti.2024.2637